OQ Trademark

Trademark Overview

On Thursday, March 12, 2026, a trademark application was filed for OQ with the United States Patent and Trademark Office. The USPTO has given the OQ trademark a serial number of 79452174. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, July 13, 2026. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The OQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment and prevention of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment and prevention of dermatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; pharmaceutical preparations ...
oq

General Information

Serial Number79452174
Word MarkOQ
Filing DateThursday, March 12, 2026
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, July 13, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment and prevention of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment and prevention of dermatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; pharmaceutical preparations for use as a preparatory regimen in connection with bone marrow transplants; pharmaceutical preparations for the treatment and prevention of metabolic diseases; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for inhibiting blood platelet aggregation.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 29, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Thursday, June 18, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 29, 2026LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, July 1, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 1, 2026APPLICATION FILING RECEIPT MAILED
Monday, July 13, 2026ASSIGNED TO EXAMINER

Related Keywords

pharmaceutical preparations prevention treatment diseases disorders ophthalmic infectious dermatological respiratory